All stock lists
Harrow, Inc. (NASDAQ:HROW)
US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
28.44+0.29 (+1.03%)
Insider Score
––Not scored
HROW Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
HROW Stock Insider Trading Activity
HROW stock’s insider trading shows 4 purchases for an estimated $468.72K and 1 sale on the open market for an estimated $450.00K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Shojaei Amir Other | Option exercise | 11,250 | $35.96 | $404.55K | New | 11,250 | Aug 14, 2026 | — | Form 4 |
| Shojaei Amir Other | Sell | 11,250 | $40.00 | $450.00K | 100% | 0 | Aug 14, 2026 | — | Form 4 |
| Graves Adrienne L Director | Buy | 1,000 | $31.07 | $31.07K | New | 1,000 | May 18, 2026 | BCluster BuyFirst Buy | Form 4 |
| SILVERNAIL LAUREN P Director | Buy | 1,000 | $31.00 | $31.00K | New | 1,000 | May 18, 2026 | BCluster BuyFirst Buy | Form 4 |
| BAUM MARK L CEO | Buy | 10,000 | $30.20 | $302.00K | 0.3% | 2,996,130 | May 14, 2026 | BCluster BuyFirst Buy | Form 4 |
| BOLL ANDREW R. CFO | Buy | 3,500 | $29.90 | $104.65K | 0.4% | 814,679 | May 14, 2026 | BCluster BuyFirst Buy | Form 4 |
| Opaleye Management Inc. Other | Sell | 134,000 | $39.67 | $5.32M | 3.6% | 3,622,000 | Mar 4, 2026 | — | Form 4 |
| Opaleye Management Inc. Other | Sell | 4,263 | $39.67 | $169.11K | 6.7% | 59,428 | Mar 4, 2026 | — | Form 4 |
| Opaleye Management Inc. Other | Sell | 1,309 | $39.15 | $51.25K | 2.0% | 63,691 | Mar 3, 2026 | — | Form 4 |
| Opaleye Management Inc. Other | Sell | 59,000 | $39.15 | $2.31M | 1.5% | 3,756,000 | Mar 3, 2026 | — | Form 4 |
| Opaleye Management Inc. Other | Sell | 5,000 | $54.18 | $270.90K | 7.1% | 65,000 | Feb 27, 2026 | — | Form 4 |
| Opaleye Management Inc. Other | Sell | 20,000 | $53.35 | $1.07M | 22.2% | 70,000 | Jan 6, 2026 | — | Form 4 |
| BOLL ANDREW R. CFO | Option exercise | 60,000 | $3.95 | $237.00K | 7.7% | 837,844 | Dec 12, 2025 | — | Form 4 |
| BOLL ANDREW R. CFO | Tax withheld | 26,665 | $47.06 | $1.25M | 3.2% | 811,179 | Dec 12, 2025 | — | Form 4 |
| BAUM MARK L CEO | Tax withheld | 79,994 | $47.06 | $3.76M | 2.6% | 2,986,130 | Dec 12, 2025 | — | Form 4 |
| BAUM MARK L CEO | Option exercise | 180,000 | $3.95 | $711.00K | 6.2% | 3,066,124 | Dec 12, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Sell (S) — Open-market or private sale
- Tax withheld (F) — Shares withheld to pay tax or an exercise price
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.